STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Aldeyra Therapeutics, Inc.

Filed

August 10, 2022

Period of Report

August 8, 2022

Accession Number

0001062993-22-017623